2016 half-year activity | Bourse Reflex
Accueil > Actualités > Communiqués

2016 half-year activity

Mardi 19 Jul 2016 à 17:50

(Unaudited data)
 

CUMULATIVE ACTIVITY AS OF THE END OF JUNE 2016

thousands of euros 2015 2016 Variation at current exchange rates Variation at constant exchange rates
France 166,448 170,963 +2.7% +2.7%
Europe (excluding France) 70,600 75,257 +6.6% +11.8%
North America 30,087 30,177 +0.3% +1.3%
Other countries 8,438 7,907 -6.3% -1.0%
Group total 275,573 284,304 +3.2% +4.8%

 

thousands of euros 2015 2016 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 153,545 156,148 +1.7% +1.8%
OTC Specialties 121,910 127,462 +4.6% +8.1%
Other 118 694 +488.1% +489.0%
Group total 275,573 284,304 +3.2% +4.8%



ACTIVITY BY QUARTER (variation at current exchange rates)

thousands of euros 1st quarter 2nd quarter
2015 2016 Var. 16/15 2015 2016 Var. 16/15
France 89,584 90,494 +1.0% 76,864 80,469 +4.7%
Europe (excluding France) 40,657 43,685 +7.4% 29,943 31,572 +5.4%
North America 17,193 16,064 -6.6% 12,894 14,113 +9.5%
Other countries 4,622 3,846 -16.8% 3,816 4,061 +6.4%
Group total 152,056 154,089 +1.3% 123,517 130,215 +5.4%

 

thousands of euros 1st quarter 2nd quarter
2015 2016 Var. 16/15 2015 2016 Var. 16/15
Non-proprietary Homeopathic Medicines 79,191 80,147 +1.2% 74,354 76,001 +2.2%
OTC Specialties 72,880 73,743 +1.2% 49,030 53,719 +9.6%
Other -15 199 - 133 495 +272.2%
Group total 152,056 154,089 +1.3% 123,517 130,215 +5.4%



HIGHLIGHTS OF THE SECOND QUARTER 2016

Despite a negative impact of the evolution of the Rouble and, to a lesser extent, of the Dollar, sales in the second quarter of 2016 rose by 5.4% (+7.3% at constant exchange rate) in comparison to the 2015 second quarter.
Activity is growing in most countries, except in Spain and Italy.

Operational income in the first half of 2016 should rise in comparison to 2015.

In the USA, the last class action procedure against the medicine Oscillococcinum® has been rejected unanimously by the jury of the Los Angeles Court in California. This verdict may be appealed.
In Canada, the federal department of health, Health Canada, got back on its statements of the end of July 2015 and authorizes to maintain the indications of use on medicines against cough, cold and flu for children under 12. By March 31, 2017, a claim on the packaging must state the grounds of such allegations.

Our company continues with the same passion the development of homeopathy in the world.

Our next update:
September 8, 2016: at market close, publication of 2016 half-year results.
Person responsible for FINANCIAL information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at: www.boironfinance.com



Partager sur Facebook
Article Précédent :
Activité du premier semestre 2016
Article Suivant :
Progression de 90% du chiffre...

Ecrire un commentaire

J'accepte la charte et que mon commentaire soit publié sur BourseReflex.com 

Les autres actualités


Retour vers 'Communiqués' »




Mots-clés : Dollar   Euros   Usa   Thousands   Rates   Homeopathic   Against   Health  
Sociétés citées dans cette news : Boiron   FINANCIAL  

Si vous passez un ordre de bourse sur le CAC40 le vendredi soir à 18h, quand sera t-il éxécuté?